NDC 61703-304-36
Cytarabine 20 mg/mL
CYTARABINE · INJECTION, SOLUTION
Cytarabine is a chemotherapy medication given by injection into the vein that is used to treat certain types of cancer, including leukemia and lymphoma. It works by interfering with cancer cell growth and division.
Key Facts
- Brand Name
- Cytarabine
- Generic Name
- CYTARABINE
- NDC Code (Package)
61703-304-36- NDC Code (Product)
61703-304- Manufacturer
- Hospira, Inc.
- Strength
- 20 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- ANDA072945
- Drug Class
- Nucleoside Metabolic Inhibitor [EPC]
- Marketing Start
- 02/28/1994
Recall History
No Recall HistoryView Full Drug Page
Cytarabine — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.